APA (7th ed.) Citation

Alshammari, F., Alrajhi, A. M., & Howaidi, J. (2025). Risk of infections in bispecific antibody therapy for multiple myeloma: A comprehensive review of literature. Hematology, 30(1), 1. https://doi.org/10.1080/16078454.2024.2448898

Chicago Style (17th ed.) Citation

Alshammari, Fahad, Abdullah M. Alrajhi, and Jude Howaidi. "Risk of Infections in Bispecific Antibody Therapy for Multiple Myeloma: A Comprehensive Review of Literature." Hematology 30, no. 1 (2025): 1. https://doi.org/10.1080/16078454.2024.2448898.

MLA (9th ed.) Citation

Alshammari, Fahad, et al. "Risk of Infections in Bispecific Antibody Therapy for Multiple Myeloma: A Comprehensive Review of Literature." Hematology, vol. 30, no. 1, 2025, p. 1, https://doi.org/10.1080/16078454.2024.2448898.